Cathepsin-D and tumor associated antigen DF3 in salivary gland neoplasia. Differential diagnostic and prognostic applications.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Pathology, Research and Practice

• Publication date

  1994-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0344-0338(11)80444-9PMID 7540754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients

  2005cited by this paper
• Estrogen receptor assay in polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma of salivary gland origin. An immunohistochemical study.

  1994cited by this paper
• Salivary duct carcinoma

  1993cited by this paper
• Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays.

  1992cited by this paper
• Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status.

  1992cited by this paper
• Salivary gland neoplasms : General considerations

  1991cited by this paper
• Prognostic significance of the estrogen‐regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

  1990cited by this paper
• Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles.

  1990cited by this paper
• Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.

  1990cited by this paper
• WHO International Histological Classification of Tumours. Tentative Histological Classification of Salivary Gland Tumours.

  1990cited by this paper
• Cathepsin D and prognosis in breast cancer.

  1990cited by this paper
• Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

  1989cited by this paper
• Structures at the proteolytic processing region of cathepsin D.

  1988cited by this paper
• Immunocytochemistry is Automated: Development of A Robotic Workstation Based Upon the Capillary Action Principle

  1988cited by this paper
• Immunohistochemical distribution of the 52-kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness.

  1987cited by this paper
• Insulin-like growth factor II receptor as a multifunctional binding protein

  1987cited by this paper
• Estrogen‐induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?

  1987cited by this paper
• Steroid hormone receptors in human salivary gland tumours.

  1987cited by this paper
• Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.

  1986cited by this paper
• Immunolocalization of cathepsin D in normal and neoplastic human tissues.

  1986cited by this paper
• Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.

  1985cited by this paper
• Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

  1984cited by this paper
• Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.

  1984cited by this paper
• International Histological Classification of Tumours

  1981cited by this paper
• Antifungal Chemotherapy

  1980cited by this paper
• Second primary cancers in patients with tumours of the salivary glands.

  1977cited by this paper
• Recessive inheritance of a congenital malformation syndrome: unilateral absence deformity of leg and congenital cataracts.

  1968cited by this paper
• The unique association between salivary gland cancer and breast cancer.

  1968cited by this paper

• Causal relationship between cathepsins and major salivary gland neoplasms: a bidirectional Mendelian randomization study

  2024cites this paper
• Immunohistochemical analysis of cathepsin-D in benign and malignant salivary gland neoplasms. Evaluation of its role as a prognostic indicator

  2022influential citation
• Type of Article: Review TITLE: ROLE OF CATHEPSIN IN ORAL DISEASE – A review

  2020cites this paper
• Cathepsins in oral diseases

  2019cites this paper
• Infiltración de células inmunocompetentes en los tumores malignos de glándulas salivares

  2014cites this paper
• Immuno-histochemical evaluation of Cathepsin D in malignant salivary gland carcinomas.

  2012influential citation
• The dilemma: Does tissue expression of cathepsin D reflect tumor malignancy? The question: Does the assay truly mirror cathepsin D mis-function in the tumor?

  2010cites this paper
• Immunohistochemical localization of lysosomal cathepsin D in schwannomas

  2006cites this paper
• Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications

  2004cites this paper
• Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer.

  2000cites this paper